Gene therapy trials in Inherited Retinal Diseases (IRDs) present unique challenges for biopharma drug developers. Choosing MERIT as your clinical endpoint expert gives you access to solutions based on experience supporting 31 #genetherapy trials. Learn about common challenges and how MERIT solves for these in our info sheet: https://lnkd.in/gmGWFCG8 #MERITCRO #YourClinicalEndpointExpert #genetherapy #clinicaltrials #inheritedretinaldiseases #clinicalresearch
MERIT CRO
Biotechnology Research
Madison, Wisconsin 4,155 followers
MERIT is a global clinical trial endpoint services provider offering reliable expertise in our therapeutic areas.
About us
MERIT is an innovative clinical endpoint expert providing attentive expertise in our therapeutic areas. We partner with CROs, pharma, and biotech companies to deliver reliable endpoint services in global clinical trials. Together our work advances and accelerates the improvement of therapeutic options for patients worldwide. We have a proven track record providing endpoint expertise to 12 of the top 20 global pharmaceutical companies. We prioritize a collaborative, partnership-driven approach for all projects with scalable solutions and personalized attention. If you’re looking for a partner that will bring dedication and expertise to your clinical trial, consider MERIT.
- Website
-
https://www.meritcro.com/?utm_source=LinkedIn&utm_medium=CompanyPage&utm_campaign=Referral
External link for MERIT CRO
- Industry
- Biotechnology Research
- Company size
- 51-200 employees
- Headquarters
- Madison, Wisconsin
- Type
- Privately Held
- Founded
- 2012
- Specialties
- Ophthalmology clinical trials, corneal endothelial cell count, optical coherence tomography, technician and equipment certification, imaging CRO, Cloud-based imaging platform, Respiratory clinical trials, Contract Research Organization, Respiratory CRO, COPD clinical trials, Asthma clinical trials, AMD clinical trials, Oncology clinical trials, and Clinical Endpoint Assessment
Products
![Click here to view EXCELSIOR Imaging Software]()
EXCELSIOR Imaging Software
Picture Archiving & Communication System (PACS) Software
MERIT’s EXCELSIOR technology platform increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools designed based on our extensive collaboration with biopharma companies. With MERIT your study data and images can easily be shared between clinical sites, reading centers, CROs, and Sponsors for maximum transparency. This makes managing global trials involving multiple reading centers and analysis of numerous modalities not only feasible, but practical.
Locations
-
Primary
Get directions
6527 Normandy Lane, #100
Madison, Wisconsin 53719, US
-
Get directions
2865 Stoner Ct
North Liberty, Iowa 52317, US
-
Get directions
Room 208, 62 Yanqi Road, Wanghai Street
Jiaxing, Haiyan County, CN
-
Get directions
333 Caoxi North Road
Room 1104
Shanghai, Xuhui District, CN
Employees at MERIT CRO
-
Yijun Huang
CEO at MERIT CRO, Inc.
-
Laura Erker
Director of Ophthalmology Reading Center Operations at MERIT CRO Clinical trial endpoint expert
-
Julia Oxley, MBA
Experienced business professional with more than 16 years leading the business development, budgeting, contracting, and operations at several roles…
-
Laura Jacobs
Proposal Development Specialist
Updates
-
NIH posted about a recent analysis from the AREDS and AREDS2 #clinicaltrials of #AgeRelatedMacularDegeneration (AMD) that showed taking supplements with antioxidant vitamins and minerals may slow the progression of late-stage dry AMD.
In a new analysis, NIH researchers have found that taking a daily supplement containing antioxidant vitamins and minerals slows progression of late-stage dry age-related macular degeneration (AMD), potentially helping people with late-stage disease preserve their central vision. https://bit.ly/3xVXyER #AMD #MacularDegeneration #research #science #NIH
-
Today is Glioblastoma Awareness Day. We join the National Brain Tumor Society in raising awareness about one of the most common, complex, treatment-resistant, and deadliest types of brain cancer: braintumor.org/gbmday #GBMDay
-
-
What are the advantages to attentive site support? MERIT's VP of Marketing, Contract, & Partnership Management, Julia Oxley, MBA, outlines MERIT's differentiators and benefits for #respiratory trials. Learn more about our respiratory solutions: https://lnkd.in/g3h6VFGB #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch #spirometry #pulmonary
-
Does your current endpoint services provider have the experience and scalability you need to move your programs ahead? If it’s time to make a change, consider what you can gain by partnering with MERIT. Check out our latest info sheet: https://lnkd.in/gzuXXr6c #clinicaltrials #clinicalresearch #MERITCRO #YourClinicalEndpointExpert
-
We've arrived in Stockholm and are ready for the #ASRS2024 meeting to start! This is a great conference to learn about the latest clinical and technological advances in retina therapies. Stop by booth # 520 this week to start a conversation! #clinicaltrials #clinicalresearch #MERITCRO #YourClinicalEndpointExpert #ophthalmology #imagingsolutions
-
-
Modern Retina shared interesting #preclinical results about the effect of an experimental drug that targeted telomerase to suppress abnormal vascular growth in mice retina. It could represent a new approach for treating #AgeRelatedMacularDegeneration. #ophthalmology
A team of researchers at the Ohio State University found that in mice an enzyme related to cell growth and division is a culprit in the blood vessel invasion in the back of the eye that causes blurred central vision in wet AMD. Read more: https://lnkd.in/eDRXzQBg
Study zeroes in on new target for treatment of one type of macular degeneration
modernretina.com
-
Our CEO and Co-Founder, Yijun Huang, PhD, provides an overview of MERIT's clinical endpoint expertise in this short video. Learn more: https://lnkd.in/eJ8DjR3E #MERITCRO #YourClinicalEndpointExpert #clinicaltrials #clinicalresearch #imagingsolutions #endpointassessment
-
July is #DryEyeAwarenessMonth. Learn the causes, types, risk factors, and symptoms at https://lnkd.in/giXH7f-Z
-
-
Do you have 5 yrs of #ophthalmology image processing experience? Check out our Segmentation Manager opening! This position will provide segmentation training & support for our IQCS (Imaging Quality Control Specialist) team. This is a fully remote role with a robust benefits package. Learn more & apply: https://lnkd.in/gRCY9FMg #careers #careers #clinicaltrials #recruiting #remoteopportunity #workfromhomejobs #workfromhomeopportunities #lifesciencescareers #MERITCROCareers #MERITCRO #YourClinicalEndpointExpert
-